Trump’s pick for FDA to test ‘due diligence’ of Agency’s science

Bloomberg Law, November 25, 2024: Dr. Marty Makary has been named by Donald Trump to lead the FDA. The Johns Hopkins surgeon has been an outspoken critic of FDA’s relationships with industry and his appointment could shake up the status quo. NCHR and other experts are optimistic that Dr. Makary will encourage the agency to reduce conflicts of interest and hold industry to a higher standard for FDA approval of medical products and food safety.

The post Trump’s pick for FDA to test ‘due diligence’ of Agency’s science first appeared on National Center for Health Research.

The post Trump’s pick for FDA to test ‘due diligence’ of Agency’s science appeared first on National Center for Health Research.